Xeno Labs BPC-157 – 10mg

Recommended Dosage:
250-500mcg (micrograms) per day via subcutaneous injection. Most people start with 250mcg once daily and increase to 500mcg if needed. Can split into 250mcg twice daily (morning and evening) for better results.

How to Take:
Inject subcutaneously (under the skin) using an insulin syringe. Common injection sites: belly fat, thigh, or upper arm. Inject as close to the injured area as possible for best results, though systemic effects work throughout your body regardless.

When to Inject:
Can inject any time of day. Many prefer morning injection or split dose (morning and evening). For specific injuries, inject near the injury site before training or bed.

Reconstitution:
BPC-157 typically comes as lyophilized powder. Reconstitute with bacteriostatic water. Common concentration: 5mg vial + 2ml bacteriostatic water = 2.5mg/ml. For 250mcg dose, inject 0.1ml (10 units on insulin syringe).

Cycle Duration:
Run for 4-8 weeks for most injuries. Acute injuries: 4-6 weeks. Chronic conditions: 6-12 weeks. Can run continuously until injury heals, then stop. No need to cycle off if still healing.

Storage:
Powder: Store in freezer or refrigerator. Reconstituted: Keep refrigerated and use within 30 days. Bring to room temperature before injecting.

Most Common (Very Rare):

• Mild nausea (uncommon)
• Dizziness when first starting (rare)
• Injection site redness or irritation
• Headache (rare)

Serious Side Effects:
None documented in studies. BPC-157 has an excellent safety profile with no known toxicity even at very high doses in animal studies. No organ damage observed. No hormonal disruption.

Important Notes:
BPC-157 is extremely well-tolerated. Side effects are minimal to non-existent for most users. The peptide is not toxic to liver, kidneys, or any organs based on extensive animal research.

Active Ingredient:
BPC-157 (Body Protection Compound 157, Pentadecapeptide BPC 157)

Form:
Lyophilized powder for reconstitution with bacteriostatic water

Intended Use:
Primary research use: Investigating tissue healing and regenerative properties in preclinical studies.
Primary practical use: Accelerating recovery from muscle/tendon/ligament injuries, gut health restoration, inflammation reduction, organ protection.

Peptide Sequence:
15 amino acids: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val

Mechanism of Action:
Multiple pathways:

• Angiogenesis: Promotes formation of new blood vessels via VEGF (vascular endothelial growth factor) pathway
• Growth factor modulation: Activates JAK2 signaling and increases growth hormone receptor activity
• Collagen synthesis: Enhances collagen formation through FAK-paxillin pathway
• Anti-inflammatory: Reduces pro-inflammatory cytokines and modulates inflammatory pathways
• Fibroblast activation: Stimulates fibroblast proliferation for tissue repair
• Nitric oxide system: Interacts with NO system for vasodilation and healing
• Cytoprotection: Protects cells from oxidative stress and apoptosis

Half-Life:
Less than 30 minutes in blood (but healing effects persist much longer due to downstream signaling)

Detection Time:
Up to 4 days in urine via mass spectrometry

Bioavailability:
High via subcutaneous injection
Moderate via oral administration (some degradation in digestive system)

Metabolization:
Metabolized in liver, excreted in urine

Molecular Formula:
C62H98N16O22

Molecular Weight:
1419.55 g/mol

Administration:
Subcutaneous injection (preferred method) or oral administration. Injection provides superior bioavailability and more direct tissue effects.

Typical Vial Sizes:
5mg or 10mg per vial (powder form)

Storage:
Powder: -20°C (freezer) or 2-8°C (refrigerator)
Reconstituted: 2-8°C (refrigerator), use within 30 days

Safety Profile:
Extensive animal studies show no toxicity across wide dose range (6 μg/kg to 20 mg/kg). No organ damage observed in liver, spleen, lung, kidney, brain, thymus, prostate, or ovaries. No lethal dose achieved in studies.

Also Known As:
Body Protection Compound 157, Pentadecapeptide BPC 157, BPC-157